CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 511951-512286
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/68a7101a90454172c91785d8c352f776a82df5d4","sourcedb":"CORD-19","sourceid":"68a7101a90454172c91785d8c352f776a82df5d4","text":"Ramatroban might be useful as an additional therapy to decrease clinical and laboratory exacerbations; further, it has been found to be reasonably safe for Japanese patients with MS. ELND002 is a potent and selective pegylated small molecule alpha-4 integrin inhibitor currently being evaluated for the treatment of multiple sclerosis.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T40470","span":{"begin":0,"end":182},"obj":"Sentence"},{"id":"T40537","span":{"begin":183,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T40470","pred":"source","obj":"CORD-19-Sentences"},{"subj":"T40537","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1131","span":{"begin":0,"end":335},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1131","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T112","span":{"begin":0,"end":182},"obj":"Sentence"},{"id":"T113","span":{"begin":183,"end":335},"obj":"Sentence"}],"attributes":[{"subj":"T112","pred":"source","obj":"CORD-19_Custom_license_subset"},{"subj":"T113","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T2209","span":{"begin":179,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A2209","pred":"uberon_id","subj":"T2209","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"},{"subj":"T2209","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T3271","span":{"begin":179,"end":181},"obj":"Disease"},{"id":"T3272","span":{"begin":316,"end":334},"obj":"Disease"},{"id":"T30268","span":{"begin":179,"end":181},"obj":"Disease"},{"id":"T52775","span":{"begin":316,"end":334},"obj":"Disease"}],"attributes":[{"id":"A3271","pred":"mondo_id","subj":"T3271","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A3272","pred":"mondo_id","subj":"T3272","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A97567","pred":"mondo_id","subj":"T30268","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A33454","pred":"mondo_id","subj":"T52775","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"subj":"T3271","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T3272","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T30268","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T52775","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ecdb","default":true},{"id":"Epistemic_Statements","color":"#ecc193"},{"id":"CORD-19_Custom_license_subset","color":"#a793ec"},{"id":"CORD-19-PD-UBERON","color":"#98ec93"},{"id":"CORD-19-PD-MONDO","color":"#ec93b2"}]}]}}